# Resection+Highly Purified CTL Versus Resection Alone for HCC

> **NCT02709070** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 210 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** resection
- **PROCEDURE:** highly-purified CTL

## Key facts

- **NCT ID:** NCT02709070
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2020-03
- **Final completion:** 2022-03
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2016-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02709070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02709070, "Resection+Highly Purified CTL Versus Resection Alone for HCC". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02709070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*